The findings suggest that CDDO-TFEA can inhibit cell cycle progression and induce apoptosis in GBM cells in vitro, possibly though its inhibition of Cyclin B1, CDK1 expression, and Cyclin B1/CDK1 association and the promotion of CHK1 and p-CHK2 expression. Here, CCNB1 is linked to glioblastoma.